Total medical devices industry M&A deals worth $1.2bn were announced in the US in May 2021, with Allergan Aesthetics’ $550m acquisition of Soliton being the sector’s biggest investment, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 57.6% over the previous month of $2.71bn and a drop of 79.7% when compared with the last 12-month average of $5.66bn.
The US held a 36.39% share of the global medical devices industry M&A deal value that totalled $3.16bn in May 2021.
In terms of M&A deal activity, the US recorded 20 deals during May 2021, marking a decrease of 9.09% over the previous month and a rise of 11.11% over the 12-month average.
US medical devices industry M&A deals in May 2021: Top deals
The top five medical devices industry M&A deals accounted for 97.8% of the overall value during May 2021.
The combined value of the top five medical devices M&A deals stood at $1.13bn, against the overall value of $1.2bn recorded for the month.
The top five medical devices industry M&A deals of May 2021 tracked by GlobalData were:
1) Allergan Aesthetics’ $550m acquisition of Soliton
2) The $260m acquisition of Nexcelom Bioscience by PerkinElmer
3) Roman Health Ventures’ $225m acquisition of Modern Fertility.
4) The $60m acquisition of OBP Medical by CooperSurgical
5) DarioHealth’s acquisition of PsyInnovations for $30m.
